세계 복강경 기구 시장 규모는 2025-2032년 예측 기간 동안 9.83%의 CAGR로 2024년 161억 달러에서 2032년 340억 9,000만 달러로 확대될 것으로 예상됩니다. 이는 빠른 회복과 합병증 감소 등의 장점으로 인해 최소침습 수술에 대한 선호도가 높아지고 있으며, AI를 활용한 영상 처리 및 에너지 효율적인 장비와 같은 기술 발전으로 수술 결과가 더욱 향상되고 있기 때문입니다. 또한, 만성질환의 증가와 외래 수술 센터의 확대는 전 세계적으로 첨단 복강경 도구에 대한 수요를 크게 증가시키고 있습니다.
예를 들어, Intuitive Surgical에 따르면, 미국 식품의약국(FDA)은 2024년 6월에 다빈치 X 및 Xi 시스템의 라벨 업데이트를 승인했습니다. 이 변경은 근치적 전립선 절제술 치료에 대한 명확한 대응을 위해 이루어졌습니다.
세계의 복강경 기구 시장에 대해 조사했으며, 시장 개요와 함께 제품별, 용도별, 최종사용자별, 지역별 동향, 시장 진입 기업 프로파일 등의 정보를 전해드립니다.
Global laparoscopic instrument market is projected to witness a CAGR of 9.83% during the forecast period 2025-2032, growing from USD 16.10 billion in 2024 to USD 34.09 billion in 2032 owing to the increasing preference for minimally invasive surgeries due to their advantages such as faster recovery and reduced complications. Technological advancements, including AI-enabled imaging and energy-efficient devices, are further enhancing procedural outcomes. Additionally, rising chronic disease prevalence and the expansion of ambulatory surgical centers are significantly boosting the demand for advanced laparoscopic tools worldwide.
For instance, the U.S. Food and Drug Administration (FDA) approved a labelling update for the da Vinci X and Xi systems in June 2024, according to Intuitive Surgical. The change explicitly addressed radical prostatectomy treatments.
Rising Popularity of Minimally Invasive Surgeries Accelerates Demand for Laparoscopic Instruments
The global shift towards minimally invasive surgeries (MIS) has significantly boosted the adoption of laparoscopic instruments. These procedures offer benefits such as reduced pain, quick recovery, minimal scarring, and shorter hospital stays, driving both patient preference and healthcare provider adoption. As awareness of these advantages increases, so does the demand for laparoscopic techniques across surgical specialties, especially in general and gynecological surgeries. Additionally, the aging global population and increasing incidence of chronic diseases requiring surgical intervention are major contributors. Technological innovations-such as high-definition imaging, real-time navigation, and robotic-assisted laparoscopy-are further enhancing procedure efficacy and safety, making laparoscopic methods more attractive. Healthcare providers are increasingly investing in laparoscopic tools to meet this growing demand. The growing emphasis on reducing hospital-acquired infections and post-operative complications also aligns well with MIS benefits, reinforcing its role in modern surgical care. For instance, in May 2023, Cleveland Clinic reported a 20% increase in laparoscopic procedures over two years due to growing patient preference and better outcomes.
Surge in Technological Advancements in Laparoscopic Instruments
Innovations in laparoscopic technology-ranging from enhanced energy devices and high-resolution laparoscopes to robotic-assisted systems-are significantly shaping the market landscape. These advancements improve surgical precision, reduce operative time, and enhance clinical outcomes. For instance, integration of AI for real-time visualization, 4K and 3D imaging systems, and ergonomically designed instruments are enabling more efficient procedures with better safety margins. Additionally, compact and modular systems are making laparoscopic setups more cost-effective for mid-sized hospitals and ambulatory centers. The growing adoption of disposable laparoscopic instruments is also gaining momentum, driven by the need for infection control and operational efficiency. These advancements are particularly vital in complex surgeries such as urological and colorectal procedures. With industry players investing heavily in R&D and launching next-gen devices, technological progress will remain a primary catalyst for the market's long-term growth. For instance, at the 2023 International Society for Gynecologic Endoscopy (ISGE) Annual Meeting in Sanur, Bali, B. Braun introduced their newest laparoscopic device, the AESCULAP(R) EinsteinVision(R) 3.0 FI. With its three distinct FI overlay modes, this most recent version features 3D Fluorescence Imaging ("FI"), allows real-time imaging. It has many uses in minimally invasive surgery, including mapping of (sentinel) lymph nodes, visualization of bile duct anatomy, and assessment of vascular or visceral perfusion. AESCULAP(R) EinsteinVision(R) 3.0 FI's cutting-edge technology helps surgeons provide the greatest results when performing surgery or patient diagnostics.
Growing Adoption of Energy Devices Segment
Energy devices play a critical role in laparoscopic surgeries by enabling tissue dissection, coagulation, and vessel sealing, making them indispensable in both routine and complex procedures. This segment is experiencing strong demand due to their ability to improve surgical efficiency, reduce bleeding, and minimize operative time. Energy devices are increasingly used in gynecological, bariatric, and colorectal surgeries where precise tissue handling is essential. Modern devices offer enhanced safety features, user control, and integration with surgical systems, making them preferred choices for hospitals and surgical centers. Additionally, the shift towards multifunctional instruments that combine cutting, coagulation, and sealing in one tool is streamlining workflows and reducing instrument exchange, a major advantage during MIS. As the complexity and volume of laparoscopic procedures rise, the energy device segment is expected to witness substantial growth due to its clinical utility and continuous innovation. For instance, in August 2024, Olympus launched the POWERSEAL 5mm Sealer/Divider, a next-gen energy device with advanced thermal control and vessel sealing features.
Dominance of North America in the Global Market
North America continues to lead the global laparoscopic instrument market due to its advanced healthcare infrastructure, early adoption of innovative surgical technologies, and high procedure volumes. The presence of major market players, frequent FDA approvals, and a robust reimbursement framework further support regional dominance. High rates of laparoscopic surgeries for conditions such as gallbladder disease, endometriosis, obesity, and colorectal cancer contribute to steady demand. Additionally, increased focus on outpatient care and ambulatory surgical centers aligns with minimally invasive techniques, reinforcing regional growth. Continuous training programs and strong surgeon expertise in laparoscopic techniques also ensure sustained usage of these instruments. Rising investments in surgical robotics and AI-integrated systems from leading U.S. firms are expected to further strengthen the market's position in North America in the coming years. According to the American College of Surgeons (ACS), over 4 million laparoscopic procedures are performed annually in the U.S., with gynecological and general surgeries accounting for the majority.
Future Market Scenario (2025-2032F)
The future of the global laparoscopic instrument market looks promising, driven by continuous technological advancements and the growing preference for minimally invasive surgeries across various specialties. Rising patient awareness, increasing healthcare expenditures, and the proliferation of ambulatory surgical centers are set to boost demand. Innovations such as AI integration, robotic-assisted laparoscopic systems, and 4K imaging are expected to transform surgical outcomes and precision. Additionally, as the global burden of chronic conditions such as obesity, colorectal cancer, and gynecological disorders increases, the need for efficient and less invasive treatment options will drive further market expansion over the next decade. For instance, in April 2024, Medtronic introduced AI capabilities with its new Touch Surgery Live Stream, featuring 14 AI algorithms. These enhance post-operative analysis and provide AI-driven surgical insights across both laparoscopic and robotic-assisted surgeries.
Key Players Landscape and Outlook
The key players in the market are significantly investing in the development of laparoscopic instruments and are utilizing strategies such as mergers, acquisitions, partnerships, and new product launches to improve their services and competitiveness. Such efforts will propel significant growth in the market, allowing large-cap industry players to increase their presence and, therefore, find new opportunities in this market.
For example, the New York Bariatric Group (NYBG), a leading supplier of bariatric services, teamed together with Advanced Laparoscopic Surgeons of Morris in May 2024. With additional offices in Edison and Florham Park, NJ, NYBG will now have 30 locations in the tri-state area, with the goal of improving patient care and access to cutting-edge surgical methods.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.